CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension

Autor: William Rostène, Julie Frugier, Françoise Baleux, David Godefroy, Isabelle Célérier, Serge Picaud, Françoise Brignole-Baudouin, Julie Degardin, Jeffrey K. Harrison, Christophe Baudouin, José Sahel, Alexandre Denoyer
Přispěvatelé: Institut de la Vision, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de recherche des Cordeliers - Equipe 20 'ingénierie des connaissances en santé', Centre de Recherche des Cordeliers (CRC (UMR_S 872)), Université Paris Descartes - Paris 5 (UPD5)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université Paris Descartes - Paris 5 (UPD5)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), University of Florida [Gainesville] (UF), Université Paris Descartes - Paris 5 (UPD5), Université Paris Descartes - Faculté de Pharmacie de Paris (UPD5 Pharmacie), Chimie des biomolécules, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (CHNO), Centre National de la Recherche Scientifique ( CNRS ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Pierre et Marie Curie - Paris 6 ( UPMC ), CIC Quinze-Vingts, Assistance publique - Hôpitaux de Paris (AP-HP)-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Centre de Recherche des Cordeliers ( CRC (UMR_S 872) ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Department of Pharmacology & Therapeutics, College of Medicine, University of Florida, Laboratory of Toxicology, Faculty of Pharmaceutical and Biological Sciences, Université Paris Descartes - Paris 5 ( UPD5 ), Chimie des Biomolécules, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique ( CNRS ), This work was supported by INSERM grants for AD, DG, JD, WR and CB, by a UPMC grant for IC and JF, and by an NIH grant for JKH (AI058256)., Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Assistance publique - Hôpitaux de Paris (AP-HP) ( APHP ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Faculté de Pharmacie de Paris - Université Paris Descartes (UPD5 Pharmacie), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Godefroy, David
Rok vydání: 2012
Předmět:
Retinal degeneration
Male
Visual System
Ocular hypertension
Apoptosis
MESH : Cytoprotection
MESH : Receptors
CXCR4

MESH : Receptors
CXCR3

0302 clinical medicine
MESH: Animals
lcsh:Science
MESH: Stress
Physiological

MESH : Glaucoma
0303 health sciences
Neurodegeneration
Anatomy
MESH : Chemokine CXCL12
Sensory Systems
3. Good health
[SDV] Life Sciences [q-bio]
MESH : Retinal Degeneration
Medicine
MESH: Chemokine CXCL12
MESH: Glaucoma
medicine.medical_specialty
MESH: Enzyme Activation
Receptors
CXCR4

Receptors
CXCR3

MESH: Retinal Degeneration
Ocular Anatomy
Caspase 3
MESH: Receptors
CXCR4

MESH: Receptors
CXCR3

03 medical and health sciences
Humans
Rats
Long-Evans

MESH: Vision
Ocular

Biology
Intraocular Pressure
MESH: Humans
[ SDV ] Life Sciences [q-bio]
lcsh:R
MESH : Humans
Glaucoma
medicine.disease
MESH : Disease Models
Animal

eye diseases
Chemokine CXCL12
MESH: Cell Line
MESH: Ocular Hypertension
Enzyme Activation
MESH: Cytoprotection
Ophthalmology
Endocrinology
chemistry
030221 ophthalmology & optometry
Rat
lcsh:Q
Ocular Hypertension
Trabecular meshwork
MESH: Disease Models
Animal

MESH : Apoptosis
Neuroscience
MESH : Cell Line
Intraocular pressure
Anatomy and Physiology
genetic structures
[SDV]Life Sciences [q-bio]
MESH : Vision
Ocular

lcsh:Medicine
chemistry.chemical_compound
MESH: Caspase 3
Molecular Cell Biology
MESH : Caspase 3
MESH : Rats
Long-Evans

MESH : Intraocular Pressure
Multidisciplinary
Cell Death
MESH : Rats
Retinal Degeneration
Animal Models
MESH : Trabecular Meshwork
medicine.anatomical_structure
Research Article
MESH: Rats
MESH : Male
Cell Line
Model Organisms
MESH: Intraocular Pressure
MESH: Rats
Long-Evans

Stress
Physiological

Trabecular Meshwork
Ocular System
Internal medicine
medicine
MESH : Ocular Hypertension
Animals
MESH : Stress
Physiological

Vision
Ocular

030304 developmental biology
MESH: Apoptosis
[ SDV.BC.BC ] Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC]
Retinal
MESH: Male
Rats
MESH: Trabecular Meshwork
Disease Models
Animal

Cytoprotection
MESH : Animals
sense organs
MESH : Enzyme Activation
Zdroj: PLoS ONE
PLoS ONE, Public Library of Science, 2012, 7 (6), pp.e37873. ⟨10.1371/journal.pone.0037873⟩
PLoS ONE, Public Library of Science, 2012, 7 (6), pp.e37873. 〈10.1371/journal.pone.0037873〉
PLoS ONE, Vol 7, Iss 6, p e37873 (2012)
PLoS ONE, 2012, 7 (6), pp.e37873. ⟨10.1371/journal.pone.0037873⟩
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0037873⟩
Popis: International audience; Glaucoma, the most common cause of irreversible blindness, is a neuropathy commonly initiated by pathological ocular hypertension due to unknown mechanisms of trabecular meshwork degeneration. Current antiglaucoma therapy does not target the causal trabecular pathology, which may explain why treatment failure is often observed. Here we show that the chemokine CXCL12, its truncated form SDF-1(5-67), and the receptors CXCR4 and CXCR3 are expressed in human glaucomatous trabecular tissue and a human trabecular cell line. SDF-1(5-67) is produced under the control of matrix metallo-proteinases, TNF-α, and TGF-β2, factors known to be involved in glaucoma. CXCL12 protects in vitro trabecular cells from apoptotic death via CXCR4 whereas SDF-1(5-67) induces apoptosis through CXCR3 and caspase activation. Ocular administration of SDF-1(5-67) in the rat increases intraocular pressure. In contrast, administration of a selective CXCR3 antagonist in a rat model of ocular hypertension decreases intraocular pressure, prevents retinal neurodegeneration, and preserves visual function. The protective effect of CXCR3 antagonism is related to restoration of the trabecular function. These data demonstrate that proteolytic cleavage of CXCL12 is involved in trabecular pathophysiology, and that local administration of a selective CXCR3 antagonist may be a beneficial therapeutic strategy for treating ocular hypertension and subsequent retinal degeneration.
Databáze: OpenAIRE